From a study of 21 patients published May 25, 2021 by Drug Science, the results showed that there was a 96% chance that a child with severe epilepsy would have a significant reduction in seizures with whole-plant cannabis medicine. Parents also reported improvements in sleep, eating, behavior, and cognition.
This compares to the best clinical outcomes of traditional medications, including Epidiolex, of less than 50%. There was an observed reduction in seizure frequency of 84% with 'no significant adverse events'. The average dose taken was 8.9 mg THC and 276 mg CBD, with a range of terpenes, flavonoids, and other phytocannabinoids.
Before using medicinal cannabis, the patients reported using an average of 7 anti-epileptic drugs (AEDs) which was reduced to an average of 1 per patient after starting medical cannabis. 7 of the 21 patients were able to completely reduce their use of AEDs.
A summary of the research and a link to it can be found at CannabisHealthNews.co.uk.